Diabetes, obesity & metabolism

Keyphrases

Publications

volume 26, number 9, 2024

Jia-Jie Wang, Zhichao Zheng, Ying Zhang
Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life. Diabetes, obesity & metabolism 26 (9) (2024)
Christina Pelekanou, Costas A Anastasiou, Christina Mavrogianni, Greet Cardon, Stavros Liatis, Jaana Lindstrom, Luis A Moreno, Soukaina Hilal, Imre Rurik, Katja Wikström, Violeta Iotova, Konstantinos Makrilakis, Yannis Manios
Physical activity in relation to metabolic health and obesity: The Feel4Diabetes study. Diabetes, obesity & metabolism 26 (9) (2024)
Monika Ryba-Stanisławowska, Bartosz Słomiński, Małgorzata Myśliwiec
Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Ziwei Yu, Ting Zhang, Xingyu Yang, Bin Xu, Zhi Yu, Li An, Tiancheng Xu, Xinyue Jing, Yaling Wang, Mengjiang Lu
Neuregulin4-ErbB4 signalling pathway is driven by electroacupuncture stimulation to remodel brown adipose tissue innervation. Diabetes, obesity & metabolism 26 (9) (2024)
Nam Hoon Kim, Jun Sung Moon, Eun Young Lee, Ho Chan Cho, Soo Heon Kwak, Soo Lim, Min Kyong Moon, Dong-Lim Kim, Tae Ho Kim, Eunvin Ko, Juneyoung Lee, Sin Gon Kim
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial. Diabetes, obesity & metabolism 26 (9) (2024)
Yi-Wei Kao, Kun-Chi Yen, Shao-Wei Chen, Tze-Fan Chao, Yi-Hsin Chan
Early reduction in albuminuria is associated with a steeper 'dip' in initial estimated glomerular filtration rate but favourable long-term kidney outcomes in people with diabetes receiving sodium-glucose cotransporter-2 inhibitors. Diabetes, obesity & metabolism 26 (9) (2024)
Ming Liu, Weijun Gu, Li Chen, Yan Bing Li, Hongyu Kuang, Jianling Du, Agustina Alvarez, Felipe Lauand, Elisabeth Souhami, Jiewen Zhang, Weiya Xu, Qin Du, Yi-Ming Mu, null null
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial. Diabetes, obesity & metabolism 26 (9) (2024)
Christopher Moran, Jarin Herson, Stephanie Than, Taya Collyer, Richard Beare, Sarah Syed, Velandai K Srikanth
Interactions between age, sex and visceral adipose tissue on brain ageing. Diabetes, obesity & metabolism 26 (9) (2024)
Lulwa Al-Abdullah, Amy L Ahern, Paul I Welsh, Jennifer Logue
A predictive model for medium-term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions. Diabetes, obesity & metabolism 26 (9) (2024)
Blayne Welk, J Andrew McClure, Brooke Carter, Collin Clarke, Luc Dubois, Kristin K Clemens
No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery. Diabetes, obesity & metabolism 26 (9) (2024)
Dan Zhang, Jianan Zhu, Nicolai J Wewer Albrechtsen, Christopher K Rayner, Richard Saffery, Hua Zhang, Chang Chen, Chinmay S Marathe
Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus. Diabetes, obesity & metabolism 26 (9) (2024)
Xiaoxuan Li, Jia Wang, Mengqi Zhang, Xiangjun Li, Yuchen Fan, Xinbei Zhou, Yuxin Sun, Zhen-Kang Qiu
Biological aging mediates the associations of metabolic score for insulin resistance with all-cause and cardiovascular disease mortality among US adults: A nationwide cohort study. Diabetes, obesity & metabolism 26 (9) (2024)
Mousa Khalafi, Javad Tolouei Azar, Michael E Symonds, Sara K Rosenkranz, Hadi Rohani, Mahsa Ehsanifar
The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 26 (9) (2024)
Xiujian Zhang, Yingying Su, Xuanfeng Zhu
The association of diabetes with progression of sleep-disordered breathing based on a prospective cohort. Diabetes, obesity & metabolism 26 (9) (2024)
Daniel Robert Quast, Dara Lancaster, Cong Xie, Michelle J Bound, Jacqueline Grivell, Karen Louise Jones, Michael Horowitz, Juris J Meier, Chinmay S Marathe, Christopher K Rayner, Michael A Nauck
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Chloë Aernouts, Sarah P W Beldé, Julie Lambrechts, Jonathan Mertens, Kristien J Ledeganck, Sven M Francque, Christophe E M De Block
Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Hazem Ayesh, Sajida Suhail, Suhail Ayesh, Kevin Niswender
Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials. Diabetes, obesity & metabolism 26 (9) (2024)
Piaopiao Li, Khalid Alkhuzam, Joshua Brown, Yichen Zhang, Tianze Jiao, Serena Jingchuan Guo, Guillermo E Umpierrez, K M Venkat Narayan, Ambar Kulshreshtha, Francisco J Pasquel, Mohammed K Ali, Stephen R Benoit
Association between low cognitive performance and diabetes-related health indicators across racial and ethnic groups in adults with diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Manjun Luo, Mengting Sun, Tingting Wang, Jianhui Wei, Xiaorui Ruan, Kebin Chen, Jun Ou, Yige Chen, Jiabi Qin
Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis. Diabetes, obesity & metabolism 26 (9) (2024)
Xiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, Michael D Shapiro, Gregory Yoke Hong Lip, Li-Li Chen, Giovanni Targher, Christopher D Byrne, Na Tian, Tie Xiao, Chen-Xiao Huang, Yan Ni, Ming-Hua Zheng
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism 26 (9) (2024)
Toczyska Klaudia, Naila Haq, Zekun Lyu, Gavin A Bewick, Min Zhao, Hannah Rosa, Jessica Starikova, Liu Bo, Shanta Jean Persaud
The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta-cell mass and function in vitro. Diabetes, obesity & metabolism 26 (9) (2024)
Davide Tinti, Cecilia Nobili, Irene Baretta, Alice Rosso, Michela Trada, Luisa de Sanctis
Paediatric type 1 diabetes mellitus: A comparison between multi-injection therapy and advanced hybrid closed-loop pump in the first year after diabetes onset. Diabetes, obesity & metabolism 26 (9) (2024)
Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun
Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis. Diabetes, obesity & metabolism 26 (9) (2024)
Cheng Zu, Mengyi Liu, Gangling Wang, Qiguo Meng, Xiaoqin Gan, Panpan He, Chun Zhou, Ziliang Ye, Yuanxiu Wei, Xinyue Su, Yuanyuan Zhang, Xianhui Qin
Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus. Diabetes, obesity & metabolism 26 (9) (2024)
Raffaele Napoli, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Riccardo Candido, null null
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study. Diabetes, obesity & metabolism 26 (9) (2024)
Anna Palmiotti, Kirsten A Berk, Martijn Koehorst, Milaine V Hovingh, Alle T Pranger, Martijn van Faassen, Jan Freark de Boer, Eline S van der Valk, Elisabeth F C van Rossum, Monique T Mulder, Folkert Kuipers
Reversal of insulin resistance in people with obesity by lifestyle-induced weight loss does not impact the proportion of circulating 12α-hydroxylated bile acids. Diabetes, obesity & metabolism 26 (9) (2024)
Xiaojun Wang, Chunrong Lu, Xiang Li, Pengpeng Ye, Jie Ma, Xiaochun Chen
Exploring causal effects of gut microbiota and metabolites on body fat percentage using two-sample Mendelian randomization. Diabetes, obesity & metabolism 26 (9) (2024)
Yuhan Chen, Li Ma, Zhigang Han, Peng Xiong
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035. Diabetes, obesity & metabolism 26 (9) (2024)
Mingyang Sun, Zhongyuan Lu, Wan-Ming Chen, Shuang Lv, Ningning Fu, Yitian Yang, Yangyang Wang, Mengrong Miao, Szu-Yuan Wu, Jiaqiang Zhang
Metformin monotherapy versus predominantly older non-metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management. Diabetes, obesity & metabolism 26 (9) (2024)
Piaopiao Li, Hamed Kianmehr, Dawei Guan, Ambar Kulshreshtha, K M Venkat Narayan, Mohammed K Ali, Guillermo E Umpierrez, Xin Hu, Vivian A Fonseca, Lizheng Shi, Stephen R Benoit
Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial. Diabetes, obesity & metabolism 26 (9) (2024)
Harpreet S Bajaj, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, Kamilla Begtrup, Tina Vilsbøll, Julio Rosenstock
Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1-5 trials. Diabetes, obesity & metabolism 26 (9) (2024)
Nikki C C Werkman, Johanna H M Driessen, Olaf H Klungel, Nicolaas S Schaper, Patrick C Souverein, Coen D A Stehouwer, Johannes T H Nielen
Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes, obesity & metabolism 26 (9) (2024)
Jason M Samuels, Kevin D Niswender, Christianne L Roumie, Matthew D Spann, C Robb Flynn, Fei Ye, Joseph Blankush, Rebecca Irlmeier, Luke M Funk, Mayur B Patel
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery. Diabetes, obesity & metabolism 26 (9) (2024)
Jie Sun, Jie Lin, Wenqin Shen, Pan Ding, Wenjuan Yang, Li Huang, Huajian Chen
Associations of body mass index, waist circumference and the weight-adjusted waist index with daily living ability impairment in older Chinese people: A cross-sectional study of the Chinese Longitudinal Healthy Longevity Survey. Diabetes, obesity & metabolism 26 (9) (2024)
Felix Aberer, Hans Christian Haberl, Hesham Elsayed, Tina Pöttler, Daniel A Hochfellner, Julia Katharina Mader
Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy. Diabetes, obesity & metabolism 26 (9) (2024)
Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki
Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data-driven cluster analysis: A post-hoc analysis of imeglimin clinical trial data. Diabetes, obesity & metabolism 26 (9) (2024)
Sascha W Hoffmann, Janis Schierbauer, Paul Zimmermann, Thomas Voit, Auguste Grothoff, Nadine Wachsmuth, Andreas Rössler, Helmut K Lackner, Othmar Moser
Effects of light-intensity physical activity on cardiometabolic parameters in young adults with overweight and obesity: The SED-ACT randomized controlled crossover trial. Diabetes, obesity & metabolism 26 (9) (2024)
Yi Tang, Wei Liu, Wuhao Wang, Huandong Zhao, Zongshi Lu, Qiang Li, Zhencheng Yan, Hongbo He, Zhigang Zhao, Zhigang Ke, Fan Li, Weidong Tong, Fang Sun, Zhiming Zhu
Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery. Diabetes, obesity & metabolism 26 (9) (2024)
Alex E Henney, David R Riley, Ben O'Connor, Theresa J Hydes, Matthew Anson, Sizheng Steven Zhao, Uazman Alam, Daniel J Cuthbertson
Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis. Diabetes, obesity & metabolism 26 (9) (2024)
Mandala Ajie, Julia I P van Heck, Clementine E M Verhulst, Therese W Fabricius, Marijn S Hendriksz, Rory J McCrimmon, Ulrik Pedersen-Bjergaard, Bastiaan de Galan, Rinke Stienstra, Cornelis Cees J Tack
Real-life hypoglycaemia partially blunts the inflammatory response to experimental hypoglycaemia in people with type 1 diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Kathryn Cardoza, Amy Kang, Brendan Smyth, Tae Won Yi, Carol Pollock, Rajiv Agarwal, George Bakris, David M Charytan, Dick de Zeeuw, David C Wheeler, Hong Zhang, Christopher P Cannon, Vlado Perkovic, Clare Arnott, Adeera Levin, Kenneth W Mahaffey
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial. Diabetes, obesity & metabolism 26 (9) (2024)
Tianzhichao Hou, Yanyun Li, Qinghua Yan, Yulin Zhou, Minna Cheng, Kai Gu, Chunxiao Wu, Yi Pang, Pengcheng Yu, Khalil Kain, Zachary Bloomgarden, Guang Ning, Qinyu Li, Jingyan Tian, Yan Shi
The interaction effect between BMI, diabetes and age at diabetes onset on the risk of thyroid cancer: A population-based cohort study in Shanghai, China. Diabetes, obesity & metabolism 26 (9) (2024)
Ying Zhou, Minzhi Xu, Xiaoxv Yin, Yanhong Gong
Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes. Diabetes, obesity & metabolism 26 (9) (2024)
Yashdeep Gupta, Alpesh Goyal, Nikhil Tandon
Implications of antenatal 1-hour postload plasma glucose (≥ 11.6 mmol/L) for postpartum diabetes and cardiometabolic risk assessment in women with gestational diabetes: Post hoc analysis from the CHIP-F study. Diabetes, obesity & metabolism 26 (9) (2024)
Kyung Ah Han, You Cheol Hwang, Shin Je Moon, Ho Chan Cho, Hye Jin Yoo, Sung Hee Choi, Suk Chon, Kyoung-Ah Kim, Tae Nyun Kim, Jun Goo Kang, Cheol-Young Park, Jong Chul Won, Eunjoo Cho, Jeongyun Kim, Kyong-Soo Park
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study. Diabetes, obesity & metabolism 26 (9) (2024)
Emelie Brieditis, Xinjun Li, Kristina Sundquist, Filip Jansåker
Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study. Diabetes, obesity & metabolism 26 (9) (2024)
María F Andreoli, Mélissa Gentreau, Gull Rukh, Mario Perello, Helgi B Schiöth
Genetic variants of LEAP2 are associated with anthropometric traits and circulating insulin-like growth factor-1 concentration: A UK Biobank study. Diabetes, obesity & metabolism 26 (9) (2024)
Stefano Del Prato, Francesco Giorgino, Kirk Szafranski, Yeesha Poon
Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective. Diabetes, obesity & metabolism 26 (9) (2024)
Jonathan Brix Winther, Jens Juul Holst
Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity. Diabetes, obesity & metabolism 26 (9) (2024)
Xiaolei Xuan, Yongjiao Zhang, Yufan Song, Bingyang Zhang, Junjun Liu, Dong Liu, Sumei Lu
Role of protein arginine methyltransferase 1 in obesity-related metabolic disorders: Research progress and implications. Diabetes, obesity & metabolism 26 (9) (2024)